NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders - PubMed (original) (raw)

Review

. 1999 Sep-Oct;7(3):125-43.

Affiliations

• PMID: 10483932

Review

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

J H Krystal et al. Harv Rev Psychiatry. 1999 Sep-Oct.

Abstract

Antagonists of the N-methyl-D-aspartate (NMDA) subclass of glutamate receptors and agonists of the glycine-B coagonist site of these receptors have been important tools for characterizing the contributions of NMDA receptor pathophysiology to a large number of neuropsychiatric conditions and for treating these conditions. Among these disorders are Alzheimer's disease, chronic pain syndromes, epilepsy, schizophrenia, Parkinson's disease, Huntington's disease, addiction disorders, major depression, and anxiety disorders. This review will examine pathophysiological and therapeutic hypotheses generated or supported by clinical studies employing NMDA antagonists and glycine-B agonists and partial agonists. It will also consider ethical issues related to human psychopharmacological studies employing glutamatergic probes.

PubMed Disclaimer

Similar articles

• Glutamate as a therapeutic target in psychiatric disorders.
  Javitt DC. Javitt DC. Mol Psychiatry. 2004 Nov;9(11):984-97, 979. doi: 10.1038/sj.mp.4001551. Mol Psychiatry. 2004. PMID: 15278097 Review.
• Glutamate-based therapeutic approaches: NR2B receptor antagonists.
  Gogas KR. Gogas KR. Curr Opin Pharmacol. 2006 Feb;6(1):68-74. doi: 10.1016/j.coph.2005.11.001. Epub 2005 Dec 22. Curr Opin Pharmacol. 2006. PMID: 16376149 Review.
• The chemical biology of clinically tolerated NMDA receptor antagonists.
  Chen HS, Lipton SA. Chen HS, et al. J Neurochem. 2006 Jun;97(6):1611-26. doi: 10.1111/j.1471-4159.2006.03991.x. J Neurochem. 2006. PMID: 16805772 Review.
• Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators.
  Ritzén A, Mathiesen JM, Thomsen C. Ritzén A, et al. Basic Clin Pharmacol Toxicol. 2005 Oct;97(4):202-13. doi: 10.1111/j.1742-7843.2005.pto_156.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 16176554 Review.
• The NMDA receptor complex: a long and winding road to therapeutics.
  Wood PL. Wood PL. IDrugs. 2005 Mar;8(3):229-35. IDrugs. 2005. PMID: 15772895 Review.

Cited by

• The Calpain Inhibitor A-705253 Attenuates Alcohol-Seeking and Relapse with Low Side-Effect Profile.
  Vengeliene V, Moeller A, Meinhardt MW, Beardsley PM, Sommer WH, Spanagel R, Bespalov A. Vengeliene V, et al. Neuropsychopharmacology. 2016 Mar;41(4):979-88. doi: 10.1038/npp.2015.225. Epub 2015 Jul 28. Neuropsychopharmacology. 2016. PMID: 26216521 Free PMC article.
• Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.
  Horiguchi M, Hannaway KE, Adelekun AE, Jayathilake K, Meltzer HY. Horiguchi M, et al. Neuropsychopharmacology. 2012 Sep;37(10):2175-83. doi: 10.1038/npp.2012.64. Epub 2012 Jun 27. Neuropsychopharmacology. 2012. PMID: 22739469 Free PMC article.
• Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.
  Gainetdinov RR, Mohn AR, Bohn LM, Caron MG. Gainetdinov RR, et al. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11047-54. doi: 10.1073/pnas.191353298. Proc Natl Acad Sci U S A. 2001. PMID: 11572967 Free PMC article.
• Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.
  Hong LE, Summerfelt A, Buchanan RW, O'Donnell P, Thaker GK, Weiler MA, Lahti AC. Hong LE, et al. Neuropsychopharmacology. 2010 Feb;35(3):632-40. doi: 10.1038/npp.2009.168. Epub 2009 Nov 4. Neuropsychopharmacology. 2010. PMID: 19890262 Free PMC article. Clinical Trial.
• LY404187: a novel positive allosteric modulator of AMPA receptors.
  Quirk JC, Nisenbaum ES. Quirk JC, et al. CNS Drug Rev. 2002 Fall;8(3):255-82. doi: 10.1111/j.1527-3458.2002.tb00228.x. CNS Drug Rev. 2002. PMID: 12353058 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information